St. George Albert Clinic Zeged University Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01223222
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

ltx-109 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cellulitis (Phase 2)

Communicable Diseases (Phase 2)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Infections (Phase 2)

Skin Diseases (Phase 2)

Skin Diseases, Infectious (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1